Study on cellular signal transduction of Neurofibromatosis Type 2 tumor suppressor gene product (Merlin)
Study on cellular signal transduction of Neurofibromatosis Type 2 tumor suppressor gene product (Merlin)
批准号:
12671369
负责人:
ARAKI Norie
金额:
$2.5万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The neurofibromatosis type 2 (NF2) is an autosomal dominantly inherited disorder, and strongly associated with development of benign intracranial tumors including bilateral vestibular schwannomas and meningiomas. NF2 gene was recently cloned, and the protein it encodes (termed as merlin) was found to be striking similarity to the moesin-ezrin-radixin (MER) family of cytoskeleton-associated proteins. To elucidate the biological function of NF2 protein (merlin), we analyzed the cellular localization and signal transduction of merlin. 1) Cellular expression systems of mutants or wild NF2 were established, and their cellular localization was analyzed by con focal lazer scanning microscopy (CLSM). The wild merlin showed cytoplasmic and submembranous localization that was found to be directed by its nuclear export signal (NES) dependent transport mechanism. The N-terminal mutation resulted in nuclear accumulation of merlin. 2) Cellular binding proteins of merlin were purified from bovine bra … More in extracts and identified as poly ADP-ribose polymerase, DNA-PK subunits Ku-antigen 85 and 70 by the analysis of their internal ammo-acid sequences. The N-terminal (19-339) region of merlin is essential for their interaction. The immuno-precipitation, western blotting, and CLMS study confirmed their cellular co-localization. NF2 mutations impair the merlin-related complex formation and their cellular signal transport. 3) Subcellular co-localizations of merlin and PARP, overexpressed in VA13 cells and mouse embryonic fibroblast (MEF), were observed mainly in their nuclear region when cells were treated with leptomycin B (LMB), an inhibitor of NES receptor Crm1. This nuclear accumulation of merlin increased with cellular DNA damages induced by bleomycin. 4) In marked contrast to wild type cells, PARP gene deficient MEF could not accumulate merlin in their nuclear region, even after the treatments of LMB and bleomycin, whereas the overexpression of PARP in those cells worked complementary to the cellular localization of merlin. These results suggest that merlin is a cytoplasmic-nuclear shuttling protein directed by its NES-dependent transport pathway being associated with PARP. The tumor suppressive function of merlin may be linked to cellular DNA-repair and related signals via the interaction of cellular merlin binding proteins such as PARP and DNA-PKs. Less
期刊论文(35)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Araki, N., et al.: "Proteomic analysis of tumor suppressor related proteins in central nervous system"J. Chromatogr. B. (in press). (2002)
Araki, N., et al.:“中枢神经系统肿瘤抑制相关蛋白的蛋白质组学分析”J.
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Araki,N., et.al.: "Proteomic analysis of tumor suppressor related proteins in brain."Protein Science. 9,(1). 162 (2000)
Araki,N., et.al.:“大脑中肿瘤抑制相关蛋白的蛋白质组学分析。”蛋白质科学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Araki,N., et.al.: "New Development in Glycomedicine, Study of autoantibody against advanced glycation endproducts of the Maillard reaction."Elsevier Science B.V(in press). (2001)
Araki,N., et.al.:“糖医学的新发展,针对美拉德反应晚期糖基化终产物的自身抗体的研究。”Elsevier Science B.V(出版中)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Araki N., Morimasa T., Sakai T., Kamo M., Tokuoh H., Yunoue S., Miyazaki K., Abe K., Saya H., Tsugita A.: "Comparative analysis of brain proteins from p53 deficient mice by two-dimensional electrophoresis"Electrophoresis. 21. 1880-1889 (2000)
Araki N.、Morimasa T.、Sakai T.、Kamo M.、Tokuoh H.、Yunoue S.、Miyazaki K.、Abe K.、Saya H.、Tsugita A.:“p53 缺陷小鼠脑蛋白的比较分析
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 25 条
Analysis of molecular network on maintenance and differentiation of glioma stem cells
-
批准号:25640068
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.58万
-
财政年份:2013
-
负责人:ARAKI Norie
-
依托单位:
System development for microquantitative molecular analyses ofglioma stem cells
-
批准号:23659693
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2011
-
负责人:ARAKI Norie
-
依托单位:
Study of the molecular mechanism of neural tumor formation mediatedby NF1 gene deficiency
-
批准号:22390281
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.23万
-
财政年份:2010
-
负责人:ARAKI Norie
-
依托单位:
Analysis of cellular signal transduction via Neurofibromatosis tumor suppressor gene products and development of their clinical targets
-
批准号:19390382
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.9万
-
财政年份:2007
-
负责人:ARAKI Norie
-
依托单位:
Study for the cellular signal transduction of Neurofibromatosis Type 1 and Type 2 tumor suppressor gene products to establish the medical molecular target for NF1 and NF2
-
批准号:16390413
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.77万
-
财政年份:2004
-
负责人:ARAKI Norie
-
依托单位:
Study on cellular signal transduction of Neurofibromatosis Type 1 and Type 2 tumor suppressor gene products
-
批准号:14571319
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.56万
-
财政年份:2002
-
负责人:ARAKI Norie
-
依托单位:
Analysis of cellular function of Neurofibromatosis Type 2 tumor suppressor gene product (Merlin)
-
批准号:10671308
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.43万
-
财政年份:1998
-
负责人:ARAKI Norie
-
依托单位:
国内基金
海外基金
登录
查看更多内容
LPS调控TFAM/NF2介导睾丸间质细胞铁死亡抑制雄激素合成的机制研究
-
批准号:QN25H040004
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:陈显武
-
依托单位:
基质硬度微环境中 UBXN1 通过调控 NF2 泛素
化激活 YAP/TAZ 通路促进 HCC 生长转移
-
批准号:Y24H160144
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:窦常伟
-
依托单位:
抑癌基因NF2调控恶性胸膜间皮瘤核苷酸代谢的分子机制及靶向干预
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:许多
-
依托单位:
祛毒散结方通过改善肿瘤乏氧微环境抑制肿瘤相关巨噬细胞功能在NF2脑膜瘤治疗中的作用及机制研究
-
批准号:82304952
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:李仕维
-
依托单位:
NF2/merlin与DCAF1 E3泛素连接酶互作介导肿瘤抑制的机理探索
-
批准号:82360610
-
项目类别:地区科学基金项目
-
资助金额:32万元
-
批准年份:2023
-
负责人:崔岩
-
依托单位:
放射治疗NF2相关前庭神经鞘膜瘤诱发听觉神经元焦亡导致听力损伤的机制研究
-
批准号:82303686
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:孙瑶
-
依托单位:
MYC超级增强子激活促进NF2突变型脑膜瘤复发及进展的分子机制研究
-
批准号:82372752
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:宫晔
-
依托单位:
神经纤维瘤病2型NF2基因治疗安全性及有效性研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:薛璐
-
依托单位:
NF2及其磷酸化修饰通路在生理及病理性血管新生中的分子机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:王瑜
-
依托单位:
NF2基因改变通过SOX9介导的细胞周期调控参与肾癌演进的机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:梁嘉宇
-
依托单位: